Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Charles River Laboratories International, Inc. Common Stock (NY:CRL)

171.74 -5.25 (-2.97%)
Streaming Delayed Price Updated: 11:59 AM EDT, Mar 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
News headline image
CRISPR, Genetics And AI — Why 2023 Could Be The Year For Biotech Stocks ↗
Genetic medicine is a top theme now for biotech stocks. Other trends are heating up too. 
Via Investor's Business Daily
News headline image
Charles River Laboratories Adds Craig B. Thompson, M.D. to Board of Directors
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Launches Endosafe Nexus 200, Emphasizes Critical Importance of Smart Automation for Endotoxin Detection
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Why Charles River Laboratories Stock Is Jumping Today ↗
Investors liked the company's Q3 update. 
Via The Motley Fool
News headline image
Expert Ratings for Charles River ↗
Within the last quarter, Charles River (NYSE:CRL) has observed the following analyst ratings: 
Via Benzinga
News headline image
Charles River Laboratories Opens Contract Vivarium Space in Chicago, Enhancing Access to AAALAC-Accredited, Turnkey Research Program
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories to Present at November Investor Conferences
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Demonstrates Excellence in Advanced Modalities at Neuroscience 2022
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
5 Analysts Have This to Say About Charles River ↗
Within the last quarter, Charles River (NYSE:CRL) has observed the following analyst ratings: 
Via Benzinga
News headline image
Where Charles River Stands With Analysts ↗
Charles River (NYSE:CRL) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
Expert Ratings for Charles River ↗
Within the last quarter, Charles River (NYSE:CRL) has observed the following analyst ratings: 
Via Benzinga
News headline image
Charles River Announces Cell Therapy Manufacturing Capacity Expansion, Reinforcing Commitment to CDMO Clients
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Analyst Ratings for Charles River ↗
Over the past 3 months, 5 analysts have published their opinion on Charles River (NYSE:CRL) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
News headline image
United Therapeutics, Super Micro Computer, Novo Nordisk And Other Big Gainers From Wednesday ↗
U.S. stocks closed lower on Wednesday, with the Dow Jones dropping more than 500 points. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
News headline image
Charles River: Q3 Earnings Insights ↗
Charles River (NYSE:CRL) reported its Q3 earnings results on Wednesday, November 2, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Charles River beat estimated... 
Via Benzinga
News headline image
Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday ↗
Gainers Starry Group Holdings, Inc. (NYSE: STRY) rose 55.6% to close at $0.28 on Wednesday after reporting Q3 results. 
Via Benzinga
News headline image
Why Benefitfocus Shares Are Trading Higher By Around 48%? Here Are 64 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Starry Group Holdings, Inc. (NYSE: STRY) gained 56% to $0.2808 after reporting Q3 results. 
Via Benzinga
News headline image
Charles River Laboratories Announces Third-Quarter 2022 Results
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Medpace Earnings Are 'Almost Unbelievable'; MEDP Stock Flies ↗
Medpace earnings soared in Q3 as weakness in contract awards turned to strength, sending MEDP stock surging. 
Via Investor's Business Daily
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Gainers 
Via Benzinga
News headline image
Charles River and Nanoscope Therapeutics Announce Multifaceted Gene Therapy Manufacturing Partnership
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Laboratories Schedules Third-Quarter 2022 Earnings Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River Launches nAAVigation Vector Platform to Accelerate Gene Therapy Programs
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday ↗
Gainers FingerMotion, Inc. (NASDAQ: FNGR) gained 82.2% to close at $3.37. 
Via Benzinga
News headline image
Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
Micron, Charles River Laboratories And Some Other Big Stocks Moving Higher On Friday ↗
U.S. stocks traded slightly higher, with the Nasdaq Composite gaining more than 80 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 30, 2022 ↗
Upgrades 
Via Benzinga
News headline image
'Right Now, You've Still Got To Avoid The Stock,' Jim Cramer Says About This Aerospace Company ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Sherwin-Williams Co (NYSE: SHW) might go lower as the PE (price-to-earnings) multiple is still "way too high" on the stock. 
Via Benzinga
News headline image
Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
From Charles River Laboratories International, Inc.
Via Business Wire
News headline image
Charles River and Cure AP-4 Announce Gene Therapy Manufacturing Collaboration
From Charles River Laboratories International, Inc.
Via Business Wire
< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.